103 results
Page 4 of 6
8-K
EX-99.1
ixud11 ge4ml8z
17 Jan 19
Zafgen Announces Positive Results for Second Cohort
7:30am
8-K
EX-99.1
k24d bdxcqq1v5v
26 Nov 18
Zafgen Provides Update on Investigational New Drug Application forZGN-1061
7:17am
8-K
EX-99.1
tnhqruj
7 Nov 18
Zafgen Reports Third Quarter 2018 Operating and Financial Results
4:15pm
8-K
EX-99.1
1rc1e3502fu
7 Aug 18
Zafgen Reports Second Quarter 2018 Operating and Financial Results
4:21pm
8-K
EX-99.1
o373hw3w7xs
2 Aug 18
Zafgen Announces Departure of President and Chief Scientific Officer Dr. Thomas Hughes
4:24pm
8-K
EX-99.1
cfjf2uwls
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
8-K
EX-99.1
1ke7z8kvavhqzasj03rj
7 Jun 18
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
5:06pm
8-K
EX-99.1
enctti58aqtgtrfkb159
30 May 18
Zafgen, Inc. Expands Executive Leadership Team with Appointment of
5:17pm
8-K
EX-99.1
p6jruxzoonymkdpplj4
8 May 18
Zafgen Reports First Quarter 2018 Operating and Financial Results
4:09pm
8-K
EX-99.2
fpz06
12 Oct 17
Zafgen Appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to Continue as President, Appointed Chief Scientific Officer
12:00am
8-K
EX-99.1
zovs6dk qhk00830ke
12 Oct 17
Zafgen Appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to Continue as President, Appointed Chief Scientific Officer
12:00am